Breaking: Anti-VEGF Market Growth Driven by Rising Demand for Innovative Therapies
The Anti-VEGF market is on track for significant expansion, with projections indicating a market size reaching approximately 41.3 USD billion by 2035. This growth trajectory represents a compound annual growth rate (CAGR) of 4.30%, underscoring the increasing prevalence of diseases such as age-related macular degeneration (AMD) and diabetic retinopathy. As more patients seek effective treatment...
0 Comentários 0 Compartilhamentos 12 Visualizações 0 Anterior